Precision oncology has entered a new phase, as data sets mature and a new wave of tools emerges to help clinicians manage ...

Breast cancer often relapses in distant organs even when complete regression of primary tumors is achieved after initial ...

Regeneron Pharmaceuticals said on Wednesday the U.S. Food and Drug Administration has approved its drug for a type of blood ...

Relapsed/refractory peripheral and cutaneous T-cell lymphomas (R/R PTCL and CTCL) are aggressive blood cancers that often ...

Patients with ID receiving TNF inhibitors are at greater risk for cutaneous malignancy than patients who are biologic-naïve.

Cancer persists as a leading cause of mortality worldwide, underscoring the urgent need to decipher its molecular complexity for improved detection, ...

Results of Ideate-Lung01 trial at WCLC back up MSD and Daiichi Sankyo's decision to move anti-B7-H3 ADC I-Dxd into phase 3 for small cell lung cancer.

Eli Lilly's gene-silencing drug lepodisiran has been shown to reduce lipoprotein (a) levels by more than 90% for at least six months with a single injection in a phase 2 trial, reinforcing its ...

Individuals with ulcerative colitis have an increased risk for certain types of cancer based on age, instead of treatment type.